在COVID-19中使用nirmatrelvir/ritonavir治疗后的临床复苏
Daniel Camp1,2, Matthew Caputo1, Fabiola Moreno Echevarria1,2
1Robert J. Havey Institute for Global Health, Feinberg School of Medicine, Northwestern University, 710 N Lake Shore Drive, Chicago, IL, 60611, USA.
BMC infectious diseases
|September 12, 2024
概括
尼马特里尔维尔/里托纳维尔 (NM/r) 治疗后的COVID-19临床反弹比以前认为的更为常见,影响6.0%的患者. 复发病例通常是温和的,结果有利,这表明住院率低.
科学领域:
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 尼尔马特雷尔维尔/里托纳维尔 (NM/r) 是一种有效的口服抗病毒药物,用于治疗轻度至中度的COVID-19.
- 报告了临床反弹综合征,其特征是治疗后症状复发.
- 有限的数据存在于NM/r相关的COVID-19反弹频率,有助于的因素,以及日常护理的结果.
研究的目的:
- 为了确定NM/r治疗后COVID-19临床反弹的频率.
- 确定与反弹相关的潜在人口和临床因素.
- 为了评估COVID-19复发的临床结果.
主要方法:
- 对268名成年患者进行了回顾性电子病历审查,这些患者接受了NM/r治疗.
- COVID-19临床反弹的定义:症状改善,随后在5天的NM/r疗程后30天内复发/恶化.
- 对人口统计数据,并发病,疫苗接种情况和先前感染情况的分析.
主要成果:
- 6% (16/268) 的患者经历了COVID-19的临床反弹.
- 在开始NM/r后,反弹的中位时间为11天.
- 在女性,黑人患者,并发病患者和没有先前感染SARS-CoV-2的人群中观察到更高比例的反弹 (尽管在统计学上不显著).
- 只有一个患者 (6.25%) 在反弹后被住院治疗.
结论:
- 在NM/r后的COVID-19临床反弹在现实环境中比以前报告的更频繁.
- 复发病例表现出轻微的症状和有利的临床结果,住院率低.
- 进一步的研究可能会澄清导致因素,并优化管理策略.
相关概念视频
Retrovirus Life Cycles
45.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.8K
Acute Pharyngitis
489
Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
489
Acute Respiratory Failure-II
183
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
183
Classification of Illness
7.4K
The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
7.4K
Acute Respiratory Failure-III
162
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
162
Immune Response Against Viral Pathogens
764
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
764


